Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadobutrol vs Gadoteridol in CNS MRI
NCT00709852Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of gadobutrol in Central nervous system diseases, sponsored by Bayer. Started Jun 2008; status: completed.
02
Drugs
gadobutrol
03
Conditions
Central nervous system diseases
Beyond the preview
Go deeper on NCT00709852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00709852.